Efficacy and safety of adalimumab after infliximab failure in pediatric Crohn disease.


OBJECTIVES The objective of the present study was to evaluate the effectiveness and safety of adalimumab (ADA) in children with Crohn disease (CD) who experienced infliximab (IFX) failure at the population level. METHODS The present retrospective study included all of the children with CD from a pediatric-onset population-based cohort who received ADA… (More)
DOI: 10.1097/MPG.0000000000000713


6 Figures and Tables

Slides referencing similar topics